This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This MIIP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 275-303 amino acids from the C-terminal region of human MIIP.
MIIP
Reaktivität: Human, Ratte
WB, IF (p), IF (cc)
Wirt: Kaninchen
Polyclonal
AbBy Fluor® 647
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
MIIP
(Migration and Invasion Inhibitory Protein (MIIP))
IIP45 antikoerper, AA553001 antikoerper, AI853621 antikoerper, D4Wsu114e antikoerper, Iip45 antikoerper, migration and invasion inhibitory protein antikoerper, MIIP antikoerper, Miip antikoerper
Hintergrund
MIIP inhibits glioma cells invasion and down-regulates adhesion-and motility-associated genes such as NFKB2 and ICAM1. MIIP exhibits opposing effects to IGFBP2 on cell invasion.